Related Experiment Video
Updated: Dec 11, 2025

Full-Field Optical Coherence Microscopy for Histology-Like Analysis of Stromal Features in Corneal Grafts
Published on: October 21, 2022
Establishing an objective biomarker for corneal cystinosis using a threshold-based Spectral domain optical coherence
Leonie Keidel1, Carolin Elhardt1, Katharina Hohenfellner2
1Department of Ophthalmology, Ludwig-Maximilians-University, Munich, Germany.
A new semi-automated algorithm using anterior segment optical coherence tomography (AS-OCT) can objectively quantify corneal cystine crystal deposition in ocular cystinosis patients. This method aids in monitoring disease control and treatment effectiveness.
Area of Science:
- Ophthalmology
- Medical Imaging
- Biomarker Development
Background:
- Ocular cystinosis involves cystine crystal deposition in the cornea.
- Accurate quantification of these deposits is crucial for disease management.
- Anterior segment optical coherence tomography (AS-OCT) offers high-resolution imaging of the cornea.
Purpose of the Study:
- To develop a semi-automated, threshold-based image segmentation algorithm.
- To objectively quantify corneal cystine crystal deposition using AS-OCT.
- To assess the algorithm's efficacy in differentiating patients from controls.
Main Methods:
- A prospective, observational study included 88 eyes of cystinosis patients and 68 eyes of healthy controls.
- AS-OCT imaging was performed on all participants.
- A semi-automated grey scale value-based threshold algorithm was developed to quantify corneal crystals.
Main Results:
- Corneal crystals appeared as hyperreflective deposits in AS-OCT B-scans.
- The algorithm effectively delineated crystals at higher grey scale thresholds.
- Significant differences in crystal deposition were observed between patients and controls (p < 0.001).
- An age-dependent depth distribution of crystal deposition was detected.
Conclusions:
- Objective quantification of corneal cystine crystal deposition is feasible with AS-OCT.
- This quantitative method can serve as a novel biomarker.
- It holds potential for ocular disease control and topical treatment monitoring.
More Related Videos
06:15Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
07:08Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019